93 related articles for article (PubMed ID: 16433451)
1. [Cystic fibrosis: chemical drugs to cure genetic diseases].
Lallemand JY; Leclaire B; Sermet I; Lenoir G
Bull Acad Natl Med; 2005 May; 189(5):789-95; discussion 795-6. PubMed ID: 16433451
[TBL] [Abstract][Full Text] [Related]
2. Molecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies.
Odolczyk N; Zielenkiewicz P
Int J Biochem Cell Biol; 2014 Jul; 52():39-46. PubMed ID: 24735712
[TBL] [Abstract][Full Text] [Related]
3. Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis?
Lallemand JY; Stoven V; Annereau JP; Boucher J; Blanquet S; Barthe J; Lenoir G
Lancet; 1997 Sep; 350(9079):711-2. PubMed ID: 9291908
[No Abstract] [Full Text] [Related]
4. Electrodiffusional ATP movement through CFTR and other ABC transporters.
Cantiello HF
Pflugers Arch; 2001; 443 Suppl 1():S22-7. PubMed ID: 11845298
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein.
Riordan JR
Am J Hum Genet; 1999 Jun; 64(6):1499-504. PubMed ID: 10330337
[No Abstract] [Full Text] [Related]
6. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
7. CFTR structure and cystic fibrosis.
Cant N; Pollock N; Ford RC
Int J Biochem Cell Biol; 2014 Jul; 52():15-25. PubMed ID: 24534272
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis: recent structural insights.
Dorwart M; Thibodeau P; Thomas P
J Cyst Fibros; 2004 Aug; 3 Suppl 2():91-4. PubMed ID: 15463935
[TBL] [Abstract][Full Text] [Related]
9. Improvement of cystic fibrosis using antitumoral drugs: a hypothesis.
Faivre L; Bonnefont JP; Lyonnet S; Munnich A; Vekemans M
Med Hypotheses; 2000 Apr; 54(4):580-1. PubMed ID: 10859642
[TBL] [Abstract][Full Text] [Related]
10. Progress towards next-generation therapeutics for cystic fibrosis.
O'Neil DA; Fraser-Pitt D
Future Med Chem; 2014 Jun; 6(9):1067-79. PubMed ID: 25068988
[TBL] [Abstract][Full Text] [Related]
11. [Modifier genes and cystic fibrosis].
Corvol H; Flamant C; Vallet C; Clement A; Brouard J
Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
[TBL] [Abstract][Full Text] [Related]
12. Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis.
Birault V; Solari R; Hanrahan J; Thomas DY
Curr Opin Chem Biol; 2013 Jun; 17(3):353-60. PubMed ID: 23711435
[TBL] [Abstract][Full Text] [Related]
13. New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls.
Bell SC; De Boeck K; Amaral MD
Pharmacol Ther; 2015 Jan; 145():19-34. PubMed ID: 24932877
[TBL] [Abstract][Full Text] [Related]
14. Understanding how cystic fibrosis mutations disrupt CFTR function: from single molecules to animal models.
Wang Y; Wrennall JA; Cai Z; Li H; Sheppard DN
Int J Biochem Cell Biol; 2014 Jul; 52():47-57. PubMed ID: 24727426
[TBL] [Abstract][Full Text] [Related]
15. Identification of molecular determinants that modulate trafficking of DeltaF508 CFTR, the mutant ABC transporter associated with cystic fibrosis.
Tsigelny I; Hotchko M; Yuan JX; Keller SH
Cell Biochem Biophys; 2005; 42(1):41-53. PubMed ID: 15673927
[TBL] [Abstract][Full Text] [Related]
16. Identification of synergistic combinations of F508del cystic fibrosis transmembrane conductance regulator (CFTR) modulators.
Lin S; Sui J; Cotard S; Fung B; Andersen J; Zhu P; El Messadi N; Lehar J; Lee M; Staunton J
Assay Drug Dev Technol; 2010 Dec; 8(6):669-84. PubMed ID: 21050065
[TBL] [Abstract][Full Text] [Related]
17. [New therapeutic approaches to Cystic fibrosis].
Willemot JM; Sermet Gaudelus I; Lenoir G
Ann Pharm Fr; 2003 Jul; 61(4):253-8. PubMed ID: 12843958
[TBL] [Abstract][Full Text] [Related]
18. Exploiting species differences to understand the CFTR Cl- channel.
Bose SJ; Scott-Ward TS; Cai Z; Sheppard DN
Biochem Soc Trans; 2015 Oct; 43(5):975-82. PubMed ID: 26517912
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein expression increases ATP release in respiratory cystic fibrosis cells.
Naumann N; Siratska O; Gahr M; Rösen-Wolff A
J Cyst Fibros; 2005 Sep; 4(3):157-68. PubMed ID: 15964250
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis transmembrane regulator potentiators as promising cystic fibrosis therapies.
Antoniu SA
Expert Opin Investig Drugs; 2011 Mar; 20(3):423-5. PubMed ID: 21303308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
